Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

by Marta Gascón, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, Alfonso Yubero, Julián Pardo, Luis Martínez-Lostao
Published 2020-06-01

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

by Maitane Ocáriz-Díez, Maitane Ocáriz-Díez, Mara Cruellas, Mara Cruellas, Marta Gascón, Marta Gascón, Rodrigo Lastra, Rodrigo Lastra, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Ariel Ramírez-Labrada, José Ramón Paño, José Ramón Paño, Andrea Sesma, Andrea Sesma, Irene Torres, Irene Torres, Alfonso Yubero, Alfonso Yubero, Julián Pardo, Julián Pardo, Julián Pardo, Julián Pardo, Dolores Isla, Dolores Isla, Eva M. Gálvez
Published 2020-09-01

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

by Andrea Sesma, Julián Pardo, Mara Cruellas, Eva M. Gálvez, Marta Gascón, Dolores Isla, Luis Martínez-Lostao, Maitane Ocáriz, José Ramón Paño, Elisa Quílez, Ariel Ramírez, Irene Torres-Ramón, Alfonso Yubero, María Zapata, Rodrigo Lastra
Published 2020-10-01